BackAbivax Overview
Abivax - ADR

Abivax Target Price

See Abivax's analyst price targets ($160) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$85.73

Average Target Price

$155.8081.7% upside

5 analysts in the last 4 months

High: $180 | Low: $118

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-22Wedbush$11837.6% upsideOpen
2026-09-22Truist Financial$15176.1% upsideOpen
2026-09-09Goldman Sachs$15580.8% upsideOpen
2026-07-24Morgan Stanley$180110% upsideOpen
2026-07-09Piper Sandler$175104.1% upsideOpen
2026-07-02Truist Financial$15580.8% upsideOpen
2026-06-30JefferiesFaisal Khurshid$15884.3% upsideOpen
2026-06-30BTIGJulian Harrison$175104.1% upsideOpen
2026-06-03Wolfe Research$13658.6% upsideOpen
2026-06-02Morgan StanleyJudah Frommer$13254% upsideOpen
2026-06-02Wedbush$905% upsideOpen
2026-06-02Truist Financial$13557.5% upsideOpen
2026-06-02JefferiesFaisal Khurshid$905% upsideOpen
2026-02-24WedbushDavid Nierengarten$11028.3% upsideOpen
2026-01-09Morgan Stanley$14569.1% upsideOpen
2026-01-08BTIGJulian Harrison$15075% upsideOpen
2026-01-08Oppenheimer$13152.8% upsideOpen
2025-12-18GuggenheimYatin Suneja$175104.1% upsideOpen
2025-12-16Piper Sandler$14265.6% upsideOpen
2025-11-24Truist FinancialGregory Renza$14063.3% upsideOpen
2025-11-05Wolfe Research$176105.3% upsideOpen
2025-10-13BarclaysEtzer Darout$14265.6% upsideOpen
2025-10-10Guggenheim$15075% upsideOpen
2025-10-06BTIG$12040% upsideOpen
2025-09-25JMP Securities$11433% upsideOpen
2025-07-23Leerink PartnersThomas Smith$7413.7% downsideOpen
2025-07-18JMP SecuritiesJason Butler$3361.5% downsideOpen
2025-03-20Morgan Stanley$1286% downsideOpen
2024-09-10Piper SandlerAlexander Potter$4251% downsideOpen
2024-05-20BTIGJulian Harrison$4349.8% downsideOpen

Abivax (ABVX) FAQ

The latest target price for ABVX is $160. Investors often review this figure alongside Abivax's historical trend and sector peers before judging valuation or financial health.

Abivax trades near $85.73 while the consensus target sits at $160 (81.7% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ABVX's target price ($160), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Abivax's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.